Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Cell Therapy
  • Knee Osteoarthritis
  • Mesenchymal Stem Cells
Type
Interventional
Phase
Phase 1Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Controlled, randomized, double-blind clinical trial comparing CELLISTEM-OA and active comparator (triamcinolone acetonide).Masking: Triple (Participant, Care Provider, Investigator)Masking Description: The Center for Advanced Therapies will send a pre-filled syringe with the 5 cc of solution without any difference in its external appearance, regardless of the content, according to the previously randomization.Primary Purpose: Treatment

Participation Requirements

Age
Between 30 years and 75 years
Gender
Both males and females

Description

Type of study Controlled, randomized, double-blind clinical trial comparing CELLISTEM-OA and active comparator (triamcinolone acetonide). Study population Patients from the Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle who consult the trauma and rheumatology service by knee osteoa...

Type of study Controlled, randomized, double-blind clinical trial comparing CELLISTEM-OA and active comparator (triamcinolone acetonide). Study population Patients from the Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle who consult the trauma and rheumatology service by knee osteoarthritis. Patients who show interest in participating will be cited to an interview with the researchers where both the objectives and the research procedures will be explained. Sample size The sample size considered are 30 participants distributed in two groups. Group 1 (control) active comparator: triamcinolone acetonide (10mg / mL) via intra-articular, 5 cc. Group 2 (experimental): CELLISTEM-OA via intra-articular, doses of 2 x 106 cells in 5cc of saline solution. The intra-articular puncture will be performed by an orthopedic doctor specializing in knee and hip treatments using sterile technique, after cooling the skin with local ice.

Tracking Information

NCT #
NCT04863183
Collaborators
Cells for Cells
Investigators
Principal Investigator: Martha L Arango, PhD Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle